dostarlimab – Talk Bio

Actionable Insights Powered by AI

GSK and iTeos End Belrestotug TIGIT Program After Disappointing Lung Cancer Results

4 weeks ago talkbio0Tagged belrestotug, Clinical Trials, dostarlimab, Drug Development, Galaxies, immuno-oncology, iTeos, Lung-201, Malignant neoplasm of lung, Progression-Free Survival, SmithKline Beecham, TIGIT gene

GSK; iTeos; belrestotug; TIGIT; lung cancer; dostarlimab; clinical trial; drug development; GALAXIES Lung-201; immuno-oncology; progression-free survival

GSK Secures Broad Label Expansion for Jemperli in First-Line Endometrial Cancer

10 months ago talkbio0Tagged Approved, dostarlimab, immuno-oncology, Jemperli, Keytruda, Malignant neoplasm of endometrium, Pharmacotherapy, SmithKline Beecham, United States Food and Drug Administration

GSK, Jemperli, dostarlimab, endometrial cancer, FDA approval, chemotherapy, immuno-oncology, Keytruda, Merck